MFN2 and infection: At the same time, fasting BG (Control: 7.18 ± 0.6 mmol/l; Ad: 7.2 ± 0.7 mmol/l; Ad-Mfn2: 5.9 ± 0.7 mmol/l, Figure 5D) and plasma insulin levels decreased (Control: 40.0 ± 5.9 mU/l; Ad: 40.1 ± 5.9 mU/l; Ad-Mfn2: 30.9 ± 3.7 mU/l, Figure 5E) while GIR increased (Control: 17.74 ± 2.34 mg/kg/min; Ad: 17.91 ± 2.56 mg/kg/min; Ad-Mfn2: 28.16 ± 4.71 mg/kg/min, Figure 5F) markedly with Ad-Mfn2 infection.